A transcriptome-wide approach showed that LGR6 is hypermethylated in the promoter region in ∼20% of colon cancer [18], and a follow-up study found hypermethylation in up to 50% of colon cancer samples depending patient ethnicity [20]. Here, LGR6 is linked to malignant colon neoplasm.